170 related articles for article (PubMed ID: 8186195)
1. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain.
Arunachalam B; Lamb CA; Cresswell P
Int Immunol; 1994 Mar; 6(3):439-51. PubMed ID: 8186195
[TBL] [Abstract][Full Text] [Related]
2. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments.
Warmerdam PA; Long EO; Roche PA
J Cell Biol; 1996 Apr; 133(2):281-91. PubMed ID: 8609162
[TBL] [Abstract][Full Text] [Related]
3. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA; Cresswell P
J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
[TBL] [Abstract][Full Text] [Related]
4. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal.
Khalil H; Brunet A; Saba I; Terra R; Sékaly RP; Thibodeau J
Int Immunol; 2003 Oct; 15(10):1249-63. PubMed ID: 13679394
[TBL] [Abstract][Full Text] [Related]
5. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
Khalil H; Brunet A; Thibodeau J
J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
[TBL] [Abstract][Full Text] [Related]
6. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments.
Romagnoli P; Layet C; Yewdell J; Bakke O; Germain RN
J Exp Med; 1993 Mar; 177(3):583-96. PubMed ID: 8436902
[TBL] [Abstract][Full Text] [Related]
7. The invariant chain p35 isoform promotes formation of nonameric complexes with MHC II molecules.
Cloutier M; Gauthier C; Fortin JS; Thibodeau J
Immunol Cell Biol; 2014 Jul; 92(6):553-6. PubMed ID: 24638068
[TBL] [Abstract][Full Text] [Related]
8. Molecular requirements for the interaction of class II major histocompatibility complex molecules and invariant chain with calnexin.
Arunachalam B; Cresswell P
J Biol Chem; 1995 Feb; 270(6):2784-90. PubMed ID: 7852350
[TBL] [Abstract][Full Text] [Related]
9. Release of DR molecules from complexes with invariant chain through the formation of a C-terminal 25 kDa invariant chain fragment.
Demotz S; Danieli C
Mol Immunol; 1993 Dec; 30(18):1623-32. PubMed ID: 8272076
[TBL] [Abstract][Full Text] [Related]
10. Endoplasmic reticulum-associated degradation-induced dissociation of class II invariant chain complexes containing a glycosylation-deficient form of p41.
Sevilla LM; Comstock SS; Swier K; Miller J
J Immunol; 2004 Aug; 173(4):2586-93. PubMed ID: 15294975
[TBL] [Abstract][Full Text] [Related]
11. Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum.
Schreiber KL; Bell MP; Huntoon CJ; Rajagopalan S; Brenner MB; McKean DJ
Int Immunol; 1994 Jan; 6(1):101-11. PubMed ID: 8148318
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain.
Strubin M; Berte C; Mach B
EMBO J; 1986 Dec; 5(13):3483-8. PubMed ID: 3104027
[TBL] [Abstract][Full Text] [Related]
13. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP).
Zhong G; Castellino F; Romagnoli P; Germain RN
J Exp Med; 1996 Nov; 184(5):2061-6. PubMed ID: 8920896
[TBL] [Abstract][Full Text] [Related]
14. Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.
Fineschi B; Arneson LS; Naujokas MF; Miller J
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10257-61. PubMed ID: 7479763
[TBL] [Abstract][Full Text] [Related]
15. ER egress of invariant chain isoform p35 requires direct binding to MHCII molecules and is inhibited by the NleA virulence factor of enterohaemorrhagic Escherichia coli.
Cloutier M; Gauthier C; Fortin JS; Genève L; Kim K; Gruenheid S; Kim J; Thibodeau J
Hum Immunol; 2015 Apr; 76(4):292-6. PubMed ID: 25731712
[TBL] [Abstract][Full Text] [Related]
16. Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.
Brachet V; Péhau-Arnaudet G; Desaymard C; Raposo G; Amigorena S
Mol Biol Cell; 1999 Sep; 10(9):2891-904. PubMed ID: 10473634
[TBL] [Abstract][Full Text] [Related]
17. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules.
Elliott EA; Drake JR; Amigorena S; Elsemore J; Webster P; Mellman I; Flavell RA
J Exp Med; 1994 Feb; 179(2):681-94. PubMed ID: 8294875
[TBL] [Abstract][Full Text] [Related]
18. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.
Kuwana T; Peterson PA; Karlsson L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1056-61. PubMed ID: 9448284
[TBL] [Abstract][Full Text] [Related]
19. Posttranslational modifications of the Ia-associated invariant protein p41 after gene transfer.
Koch N
Biochemistry; 1988 May; 27(11):4097-102. PubMed ID: 3137970
[TBL] [Abstract][Full Text] [Related]
20. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment.
Layet C; Germain RN
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2346-50. PubMed ID: 1900941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
